Thermo Fisher Scientific (TMO) Work In Process (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Work In Process for 11 consecutive years, with $952.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Work In Process rose 0.53% year-over-year to $952.0 million; the trailing twelve-month figure through Jun 2026 stood at $952.0 million (up 0.53% YoY), and the FY2025 full-year result was $889.0 million, up 17.75% from the prior year.
• Work In Process rose to $952.0 million in Q2 2026 per TMO's latest filing, from $942.0 million in the prior quarter.
• Across five years, Work In Process topped out at $990.0 million in Q3 2025 and bottomed at $705.0 million in Q4 2023.
• Historically, Work In Process has averaged $881.8 million across 4 years, with a median of $915.5 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Work In Process advanced 17.75% in 2025, then climbed 0.53% in 2026.
• Over 4 years, Work In Process stood at $705.0 million in 2023, then increased by 7.09% to $755.0 million in 2024, then advanced by 17.75% to $889.0 million in 2025, then increased by 7.09% to $952.0 million in 2026.
• According to Business Quant data, Work In Process over the past three periods registered $952.0 million, $942.0 million, and $889.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.